$BGLC
BioNexus Gene Lab Corp Common stock
XNAS•Health Care•Services-Medical Laboratories
$1.57
▲+6.44%+$0.095
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBioNexus Gene Lab Corp Common stock
XNAS•Health Care•Services-Medical Laboratories
Why is BGLC up today? It is at $1.57 (+6.44%). See the catalyst behind the move, real-time alerts the moment BGLC spikes, and full due diligence on BGLC — key stats, earnings, dilution and insider activity. Free.
Be first to know when $BGLC makes an unusual move. Create a free account to track $BGLC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BGLC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BGLC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Low Jook Yuen Director | Acquired (grant/award) | +16K 0.5% of company | added 100% | 17K | n/a | Aug 13, 26 |
Chong Set Fui Officer | Acquired (grant/award) | +97K 3.3% of company | n/a | 97K | n/a | Aug 13, 26 |
Bin Abdul Hamid Muhammad Azrul Director | Acquired (grant/award) | +32K 1.1% of company | n/a | 32K | n/a | Aug 13, 26 |
Yap Chee Keong Director | Acquired (grant/award) | +32K 1.1% of company | n/a | 32K | n/a | Aug 13, 26 |
Tan Lee Su-Leng Officer | Acquired (grant/award) | +339K 11.5% of company | n/a | 339K | n/a | Aug 13, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-medical laboratories, closest in size first.
Here is the latest on BGLC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BGLC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BGLC last traded at $1.57, up 6.44% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The BGLC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BGLC 0 times in the last 30 days.
BGLC (BioNexus Gene Lab Corp Common stock) trades on XNAS, with a market cap of about $5M in the Services-Medical Laboratories sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BGLC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BGLC discussion
Sign in to ask a question or join the discussion.